
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $2.2B | -- | -- | $1.18 | -- |
07/31/2025 | Q2 | $2.2B | -- | -- | $1.15 | -- |
04/29/2025 | Q1 | $2B | $2.1B | $0.69 | $0.95 | -$0.26 |
02/04/2025 | Q4 | $2.2B | $2.3B | $1.33 | $1.13 | $0.20 |
10/31/2024 | Q3 | $2.2B | $2.1B | $0.89 | $1.11 | -$0.22 |
07/30/2024 | Q2 | $2.1B | $2.2B | $0.80 | $1.05 | -$0.25 |
05/02/2024 | Q1 | $2B | $2B | $0.63 | $0.84 | -$0.21 |
02/06/2024 | Q4 | $2.1B | $2.1B | $1.16 | $0.95 | $0.21 |
10/31/2023 | Q3 | -- | -- | $0.63 | $0.89 | -$0.26 |
08/02/2023 | Q2 | -- | -- | $0.45 | $0.81 | -$0.36 |
05/04/2023 | Q1 | -- | -- | $0.54 | $0.62 | -$0.08 |
02/07/2023 | Q4 | -- | -- | $0.82 | $0.79 | $0.03 |
11/01/2022 | Q3 | -- | -- | $0.07 | $0.66 | -$0.59 |
08/02/2022 | Q2 | -- | -- | $0.62 | $0.54 | $0.08 |
05/04/2022 | Q1 | -- | -- | $0.45 | $0.43 | $0.02 |
02/03/2022 | Q4 | -- | -- | $0.62 | $0.61 | $0.01 |
11/02/2021 | Q3 | -- | -- | $0.63 | $0.60 | $0.03 |
08/03/2021 | Q2 | -- | -- | $0.62 | $0.63 | -$0.01 |
05/04/2021 | Q1 | -- | -- | $0.48 | $0.37 | $0.11 |
02/04/2021 | Q4 | -- | -- | $0.82 | $0.68 | $0.14 |
10/29/2020 | Q3 | -- | -- | $0.20 | $0.50 | -$0.30 |
07/30/2020 | Q2 | -- | -- | $0.17 | $0.38 | -$0.21 |
05/05/2020 | Q1 | -- | -- | $0.21 | $0.37 | -$0.16 |
02/06/2020 | Q4 | -- | -- | $0.65 | $0.89 | -$0.24 |
10/31/2019 | Q3 | -- | -- | $0.36 | $0.82 | -$0.46 |
08/01/2019 | Q2 | -- | -- | $0.79 | $0.79 | -$0.00 |
05/02/2019 | Q1 | -- | -- | $0.52 | $0.56 | -$0.04 |
01/31/2019 | Q4 | -- | -- | $0.88 | $0.88 | $0.00 |
10/30/2018 | Q3 | -- | -- | $0.77 | $0.77 | $0.00 |
07/31/2018 | Q2 | -- | -- | $0.73 | $0.71 | $0.02 |
05/01/2018 | Q1 | -- | -- | $0.51 | $0.52 | -$0.01 |
02/01/2018 | Q4 | -- | -- | $0.76 | $0.76 | -$0.00 |
10/31/2017 | Q3 | -- | -- | $0.65 | $0.64 | $0.01 |
08/01/2017 | Q2 | -- | -- | $0.59 | $0.57 | $0.02 |
05/02/2017 | Q1 | -- | -- | $0.39 | $0.38 | $0.01 |
02/02/2017 | Q4 | -- | -- | $0.66 | $0.65 | $0.01 |
11/01/2016 | Q3 | -- | -- | $0.54 | $0.53 | $0.01 |
08/02/2016 | Q2 | -- | -- | $0.48 | $0.47 | $0.01 |
05/03/2016 | Q1 | -- | -- | $0.35 | $0.34 | $0.01 |
02/04/2016 | Q4 | -- | -- | $0.60 | $0.60 | -- |
10/29/2015 | Q3 | -- | -- | $0.49 | $0.48 | $0.01 |
Xylem reported $2.1B worth of top line sales in its most recent quarter.
Xylem announced earnings per share of $0.69 which represents a miss of analyst forecast a $0.95 per share.
Xylem reported $768M that represents $3.15 per share over the last quarter.
Xylem's earnings are forecast to grow from $3.65 per share to $4.23 per share next year representing an increase of 27.03%.
Xylem's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.